Table 2. The association of CEA and CA125 with PPF.
Variables | Categorical | Continuous | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 1 | Model 2 | ||||||||
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | ||||
CEA | 3.42 (1.74–6.72) | <0.001 | 2.58 (1.36–4.92) | 0.004 | 1.87 (1.19–2.93) | 0.006 | 1.74 (1.13–2.68) | 0.01 | |||
CA125 | 1.96 (1.08–3.55) | 0.03 | 1.88 (0.98–3.63) | 0.059 | 1.41 (1.01–1.97) | 0.043 | 1.39 (0.97–2.00) | 0.08 |
Model 1: crude; Model 2: adjusted for DLCO% pred., age, pulmonary hypertension, honeycombing, emphysema. CEA, carcinoembryonic antigen; CA125, carbohydrate antigen 125; PPF, progressive pulmonary fibrosis; OR, odds ratio; CI, confidence Interval; DLCO% pred., percent predicted for diffusion capacity of the lung for carbon monoxide.